Related Experiment Video
Updated: Oct 15, 2025

13:10
Use of Alu Element Containing Minigenes to Analyze Circular RNAs
Published on: March 10, 2020
7.5K
circ-ZNF609: A potent circRNA in human cancers
Yiguan Qian1, Yang Li1, Rongfei Li1
1Department of Urology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Journal of Cellular and Molecular Medicine
|October 26, 2021
Summary
Circular RNAs (circRNAs) are key players in human diseases. CircRNA ZNF609 (circ-ZNF609) shows potential as a diagnostic biomarker and therapeutic target for neoplasms, requiring further research.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Circular RNAs (circRNAs) are endogenous RNAs with a unique circular structure.
- Emerging evidence links circRNAs to various human diseases, particularly malignancies.
- CircRNA ZNF609 (circ-ZNF609), originating from the ZNF609 gene, is implicated in disease development and progression.
Purpose of the Study:
- To review the biogenesis and general functions of circRNAs.
- To explore the specific functional roles and molecular mechanisms of circ-ZNF609 in neoplasms and other diseases.
- To highlight the potential of circ-ZNF609 as a diagnostic and prognostic biomarker.
Main Methods:
- Literature review of existing research on circRNAs and circ-ZNF609.
- Analysis of functional roles and molecular mechanisms.
- Evaluation of biomarker potential and therapeutic applications.
Main Results:
- CircRNAs play diverse roles in cellular processes and disease pathogenesis.
- Circ-ZNF609 is involved in the development and progression of various neoplasms.
- Circ-ZNF609 exhibits potential as a diagnostic and prognostic biomarker for several diseases.
Conclusions:
- Circ-ZNF609 is a significant circRNA with implications in disease, especially cancer.
- Further research is essential to validate circ-ZNF609 as a clinical biomarker and therapeutic target.
- Understanding circ-ZNF609's mechanisms can accelerate its clinical application.
Related Concept Videos
The Nucleolus
9.5K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.5K
Abnormal Proliferation
4.7K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Rous Sarcoma Virus (RSV) and Cancer
5.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.6K
Experimental RNAi
6.4K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.4K
RNA Interference
26.7K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.7K
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K

